Radha Rajasingham

Summary

Publications

  1. pmc Integrating cryptococcal antigen screening and pre-emptive treatment into routine HIV care
    Radha Rajasingham
    Infectious Disease Institute, Makerere University, Kampala, Uganda
    J Acquir Immune Defic Syndr 59:e85-91. 2012
  2. pmc A systematic review of behavioral and treatment outcome studies among HIV-infected men who have sex with men who abuse crystal methamphetamine
    Radha Rajasingham
    Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA
    AIDS Patient Care STDS 26:36-52. 2012
  3. ncbi request reprint Timing of antiretroviral therapy after diagnosis of cryptococcal meningitis
    David R Boulware
    From the University of Minnesota, Minneapolis D R B, D B M, M A R, K H H, D A W, R R, J R, M W L, K N, T L B, P R B the Infectious Disease Institute D B M, A M, H W N, D A W, R R, J R, M W L, A K, Y C M and School of Medicine, College of Health Sciences D B M, Makerere University, Kampala, and Mbarara University of Science and Technology, Mbarara C M, K T both in Uganda the University of Cape Town, Cape Town, South Africa C S, F T, G M Johns Hopkins School of Medicine, Baltimore Y C M the Mucosal and Vaccine Research Program Colorado MAVRC, University of Colorado Denver, Aurora
    N Engl J Med 370:2487-98. 2014
  4. pmc Cryptococcal meningitis treatment strategies in resource-limited settings: a cost-effectiveness analysis
    Radha Rajasingham
    Infectious Disease Institute, Makerere University, Kampala, Uganda
    PLoS Med 9:e1001316. 2012

Detail Information

Publications5

  1. pmc Integrating cryptococcal antigen screening and pre-emptive treatment into routine HIV care
    Radha Rajasingham
    Infectious Disease Institute, Makerere University, Kampala, Uganda
    J Acquir Immune Defic Syndr 59:e85-91. 2012
    ..We provide recommendations for implementation, pre-emptive treatment, and identify the gaps in our current knowledge...
  2. pmc A systematic review of behavioral and treatment outcome studies among HIV-infected men who have sex with men who abuse crystal methamphetamine
    Radha Rajasingham
    Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA
    AIDS Patient Care STDS 26:36-52. 2012
    ..The results presented support efforts to develop and implement novel interventions to reduce crystal meth use in HIV-infected MSM...
  3. ncbi request reprint Timing of antiretroviral therapy after diagnosis of cryptococcal meningitis
    David R Boulware
    From the University of Minnesota, Minneapolis D R B, D B M, M A R, K H H, D A W, R R, J R, M W L, K N, T L B, P R B the Infectious Disease Institute D B M, A M, H W N, D A W, R R, J R, M W L, A K, Y C M and School of Medicine, College of Health Sciences D B M, Makerere University, Kampala, and Mbarara University of Science and Technology, Mbarara C M, K T both in Uganda the University of Cape Town, Cape Town, South Africa C S, F T, G M Johns Hopkins School of Medicine, Baltimore Y C M the Mucosal and Vaccine Research Program Colorado MAVRC, University of Colorado Denver, Aurora
    N Engl J Med 370:2487-98. 2014
    ..Antiretroviral therapy (ART) is essential for survival; however, the question of when ART should be initiated after diagnosis of cryptococcal meningitis remains unanswered...
  4. pmc Cryptococcal meningitis treatment strategies in resource-limited settings: a cost-effectiveness analysis
    Radha Rajasingham
    Infectious Disease Institute, Makerere University, Kampala, Uganda
    PLoS Med 9:e1001316. 2012
    ..A cost-effectiveness analysis was performed to guide stakeholders with respect to optimal CM treatment within resource limitations...